PH31606A - L-carnitine salt and compositions containing them. - Google Patents

L-carnitine salt and compositions containing them.

Info

Publication number
PH31606A
PH31606A PH50702A PH50702A PH31606A PH 31606 A PH31606 A PH 31606A PH 50702 A PH50702 A PH 50702A PH 50702 A PH50702 A PH 50702A PH 31606 A PH31606 A PH 31606A
Authority
PH
Philippines
Prior art keywords
compositions containing
carnitine
carnitine salt
salt
troches
Prior art date
Application number
PH50702A
Other languages
English (en)
Inventor
Cavazza Claudio
Cavazza Paolo
Original Assignee
Avantgarde Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avantgarde Spa filed Critical Avantgarde Spa
Publication of PH31606A publication Critical patent/PH31606A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/006Antidandruff preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
PH50702A 1994-06-20 1995-06-13 L-carnitine salt and compositions containing them. PH31606A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM940396A IT1272290B (it) 1994-06-20 1994-06-20 Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Publications (1)

Publication Number Publication Date
PH31606A true PH31606A (en) 1998-11-03

Family

ID=11402602

Family Applications (1)

Application Number Title Priority Date Filing Date
PH50702A PH31606A (en) 1994-06-20 1995-06-13 L-carnitine salt and compositions containing them.

Country Status (13)

Country Link
US (1) US5591450A (zh)
EP (2) EP0688761A2 (zh)
JP (2) JPH0827081A (zh)
KR (2) KR960000855A (zh)
AT (1) ATE165338T1 (zh)
CA (2) CA2150407A1 (zh)
DE (1) DE69502147T2 (zh)
ES (1) ES2116651T3 (zh)
HK (1) HK1004918A1 (zh)
IT (1) IT1272290B (zh)
PH (1) PH31606A (zh)
TW (1) TW300881B (zh)
ZA (2) ZA955024B (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee
AUPN115095A0 (en) * 1995-02-15 1995-03-09 Butt, Henry Lawrence Analysis of and compositions and methods for the treatment of disease
IT1276253B1 (it) 1995-12-15 1997-10-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
IT1289974B1 (it) * 1997-02-25 1998-10-19 Aldo Fassi Procedimento per la produzione di sali stabili e non igroscopici di l(-)carnitina e di alcanoli l(-)-carnitine
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
DK0951909T4 (da) 1998-03-19 2011-01-24 Sigma Tau Ind Farmaceuti Kombinationspræparat omfattende en L-carnitin eller en alkanoyl-L-carnitin, en glycosaminoglycan og/eller bestanddel deraf
KR20000050756A (ko) * 1999-01-14 2000-08-05 연규 핀 귀걸이의 제조방법과 그 제품의 구조
US6090849A (en) * 1999-03-23 2000-07-18 The Board Of Regents For Oklahoma State University Carnitine supplemented diet to prevent sudden death syndrome in breeder type poultry
ITRM20010364A1 (it) * 2001-06-25 2002-12-27 Biosalts Srl Ascorbil derivati di carnitine e composizioni cosmetiche contenenti tali derivati.
CA2519998A1 (en) * 2003-03-28 2004-10-14 Lonza Inc. Topical l-carnitine compositions
JP4539096B2 (ja) * 2004-01-16 2010-09-08 日油株式会社 油性成分被覆l−カルニチン塩粉末およびその用途
CN1322860C (zh) * 2004-08-31 2007-06-27 北京正大绿洲医药科技有限公司 左旋肉碱滴丸及其制备方法
US7572832B2 (en) * 2007-03-19 2009-08-11 Biolink Life Sciences, Inc. Non-hygroscopic L-carnitine salts
KR101633846B1 (ko) 2013-11-25 2016-06-27 주식회사 엘지화학 도전성 패턴 형성용 조성물 및 도전성 패턴을 갖는 수지 구조체
EP3275866B1 (en) * 2015-03-27 2019-12-04 Jiangsu Hengrui Medicine Co., Ltd. P-toluenesulfonate for mek kinase inhibitor, and crystal form thereof and preparation method therefor
CN107216340B (zh) * 2016-03-22 2021-05-04 中国科学院上海药物研究所 一种dppiv抑制剂的盐型及其制备方法
CN107216339B (zh) * 2016-03-22 2021-05-04 中国科学院上海药物研究所 一种dppiv抑制剂马来酸盐的多晶型及其制备方法
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3463261D1 (en) 1983-12-28 1987-05-27 Sigma Tau Ind Farmaceuti Salts of l-carnitine and alkanoyl l-carnitines and process for preparing same
FR2627385B3 (fr) * 1988-02-23 1991-08-23 Serobiologiques Lab Sa Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
US5137910A (en) * 1989-05-05 1992-08-11 C.D. Searle & Co. Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
IT1263013B (it) * 1992-10-20 1996-07-23 Avantgarde Spa Esteri della l-carnitina e di alcanoil l-carnitine con l'acido glicolico o suoi esteri e composizioni farmaceutiche contenenti tali per il trattamento di affezioni cutanee.
IT1261984B (it) * 1993-06-22 1996-06-11 Avantgarde Spa Uso di esteri della l-carnitina o di acil l- carnitine con idrossiacidi per produrre composizioni farmaceutiche per il trattamento di affezioni cutanee.
IT1272290B (it) * 1994-06-20 1997-06-16 Avantgarde Spa Sale della l-carnitina e composizioni farmaceutiche che lo contengono per il trattamento di affezioni cutanee

Also Published As

Publication number Publication date
EP0688761A2 (en) 1995-12-27
KR960000217A (ko) 1996-01-25
JPH0826984A (ja) 1996-01-30
ES2116651T3 (es) 1998-07-16
JPH0827081A (ja) 1996-01-30
CA2150407A1 (en) 1995-12-21
DE69502147T2 (de) 1998-08-13
EP0697397B1 (en) 1998-04-22
TW300881B (zh) 1997-03-21
EP0688761A3 (zh) 1996-01-17
ATE165338T1 (de) 1998-05-15
CA2152005A1 (en) 1995-12-21
ITRM940396A1 (it) 1995-12-20
KR960000855A (ko) 1996-01-25
DE69502147D1 (de) 1998-05-28
ZA955024B (en) 1996-02-08
EP0697397A1 (en) 1996-02-21
US5591450A (en) 1997-01-07
ZA955025B (en) 1996-02-08
ITRM940396A0 (it) 1994-06-20
HK1004918A1 (en) 1998-12-11
IT1272290B (it) 1997-06-16

Similar Documents

Publication Publication Date Title
PH31606A (en) L-carnitine salt and compositions containing them.
HUP0100394A3 (en) 2-phenyl substituted imidazotriazinones, process for their preparation and pharmaceutical compositions thereof
GB9410987D0 (en) High dosage pharmaceutical compositions
IL68028A0 (en) Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
HUT59591A (en) Process for producing solide, oral retarde pharmaceutical compositions
IE901119L (en) Orally administrable ibuprofen compositions
ZA83362B (en) Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
HUP0002843A3 (en) New betha-carboline compounds, a process for their preparation and pharmaceutical compositions containing them
EP0715857A3 (de) Pharmazeutische, oral anwendbare Zubereitungen enthaltend als Zerfallbeschleuniger eine wasserlösliche Aminosäure
IL119080A0 (en) Pharmaceutical compositions containing tramadol
HUP9802757A3 (en) New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
IL110201A0 (en) Novel pharmaceutical compositions
TW200716550A (en) Pharmaceutical composition comprising ritonavir
ZA943255B (en) Substituted indoles, a process for their preparation and pharmaceutical compositions containing them
IL88998A0 (en) Novel amino acid glycerides,processes for their preparation,and pharmaceutical compositions containing them
IL98260A0 (en) Hiv protease inhibiting oligopeptides,process for their preparation and pharmaceutical compositions containing them
IL99031A0 (en) Solid oral pharmaceutical compositions containing ifosfamide
IL99294A0 (en) Indolonaphthyridines,their production and pharmaceutical compositions containing them
CA2067275A1 (en) Pharmaceutical formulation containing dirithromycin
GB9321945D0 (en) A pharmaceutical composition having anti-decrepit action a process for preparation thereof
IL90219A0 (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them
AU7039691A (en) Bioavailable iron-albumin compounds, a process for the preparation thereof and pharmaceutical compositions containing them
HUP9800430A3 (en) Novel benzenesulfonamide derivatives, process for preparing them and pharmaceutical compositions containing them
ZA946260B (en) Naphthalene compounds a process for their preparation and pharmaceutical compositions containing them
GR3025160T3 (en) 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compositions containing them.